Tagrisso 40mg Tablet
By Tagrisso
Rx
10 Tablet in a Strip

Composition
Osimertinib(40mg)

Manufacturer - AstraZeneca
Corporate & Registered Office, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, 560045, Bangalore

Expires on or after
January, 2026

liver
Tagrisso 40mg Tablet is considered safe for use in individuals with liver disease. It is not necessary to adjust the dosage of Tagrisso 40mg Tablet specifically for liver-related issues. Therefore, individuals with liver conditions can typically use this medication without concerns about potential adverse effects on the liver.

kidney
Tagrisso 40mg Tablet is safe for use in patients with kidney disease. No dose adjustment is necessary.

alcohol
Consult your doctor when consuming alcohol with Tagrisso 40mg Tablet.

driving
Tagrisso 40mg Tablet typically does not impact driving ability.

pregnancy
It is unsafe to use Tagrisso 40mg Tablet during pregnancy due to potential harmful effects on the developing baby. Limited human studies and animal research suggest caution. Consult your doctor for advice.

breastfeeding
Tagrisso 40mg Tablet is likely unsafe for breastfeeding moms as it may pass into breastmilk and harm the baby, based on limited human data. It's important to take caution and consult your healthcare provider.
| Habit Forming | No |
| Chemical Class | M-Alkylindoles |
| Therapeutic Class | - |
| Action Class | Tyrosine kinase inhibitors |
₹148154
₹150154
1.33% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025
